| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |